These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38973303)

  • 1. Nicotine Enantioselectively Targets Myeloid Differentiation Protein 2 and Inhibits the Toll-like Receptor 4 Signaling.
    Jiang P; Zhang C; Wang H; Li P; Du X; Wang Y; Lyukmanova E; Lin C; Wang X
    J Chem Inf Model; 2024 Jul; 64(13):5253-5261. PubMed ID: 38973303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the chiral recognition of TLR4/MD2 with Neoseptin-3 enantiomers by molecular dynamics simulations.
    Zhang C; Wu S; Li M; Li P; Du X; Wang Y; Wang X
    Phys Chem Chem Phys; 2024 Mar; 26(12):9309-9316. PubMed ID: 38426248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine and its metabolite cotinine target MD2 and inhibit TLR4 signaling.
    Li H; Peng Y; Lin C; Zhang X; Zhang T; Wang Y; Li Y; Wu S; Wang H; Hutchinson MR; Watkins LR; Wang X
    Innovation (Camb); 2021 May; 2(2):100111. PubMed ID: 34557761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid A from lipopolysaccharide recognition: structure, dynamics and cooperativity by molecular dynamics simulations.
    Garate JA; Oostenbrink C
    Proteins; 2013 Apr; 81(4):658-74. PubMed ID: 23184816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A structural insight into the negative effects of opioids in analgesia by modulating the TLR4 signaling: An in silico approach.
    Shah M; Anwar MA; Yesudhas D; Krishnan J; Choi S
    Sci Rep; 2016 Dec; 6():39271. PubMed ID: 27982096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arachidonic acid inhibits inflammatory responses by binding to myeloid differentiation factor-2 (MD2) and preventing MD2/toll-like receptor 4 signaling activation.
    Zhang Y; Chen H; Zhang W; Cai Y; Shan P; Wu D; Zhang B; Liu H; Khan ZA; Liang G
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165683. PubMed ID: 31953218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the Role of the Hydroxyl Moiety at C14 in (+)-Opioid-Based TLR4 Antagonists via Wet-Lab Experiments and Molecular Dynamics Simulations.
    Gao J; Zhang C; Xu H; Zhang T; Wang H; Wang Y; Wang X
    J Chem Inf Model; 2024 Jul; 64(13):5273-5284. PubMed ID: 38921627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulforaphane inhibits the engagement of LPS with TLR4/MD2 complex by preferential binding to Cys133 in MD2.
    Koo JE; Park ZY; Kim ND; Lee JY
    Biochem Biophys Res Commun; 2013 May; 434(3):600-5. PubMed ID: 23583403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radix Glycyrrhizae extract and licochalcone a exert an anti-inflammatory action by direct suppression of toll like receptor 4.
    Cai M; Xu YC; Deng B; Chen JB; Chen TF; Zeng KF; Chen S; Deng SH; Tan ZB; Ding WJ; Zhang SW; Liu B; Zhang JZ
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115869. PubMed ID: 36309116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopolysaccharide (LPS) directly suppresses growth hormone receptor (GHR) expression through MyD88-dependent and -independent Toll-like receptor-4/MD2 complex signaling pathways.
    Dejkhamron P; Thimmarayappa J; Kotlyarevska K; Sun J; Lu C; Bonkowski EL; Denson LA; Menon RK
    Mol Cell Endocrinol; 2007 Aug; 274(1-2):35-42. PubMed ID: 17601656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in the discovery of myeloid differentiation 2 (MD2) modulators for inflammatory diseases.
    Chen L; Fu W; Zheng L; Wang Y; Liang G
    Drug Discov Today; 2018 Jun; 23(6):1187-1202. PubMed ID: 29330126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting the innate immune recognition of morphine and its metabolites by TLR4/MD2: an
    Zhang X; Li R; Xu H; Wu G; Wu S; Wang H; Wang Y; Wang X
    Phys Chem Chem Phys; 2023 Nov; 25(43):29656-29663. PubMed ID: 37882236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artemisinin inhibits TLR4 signaling by targeting co-receptor MD2 in microglial BV-2 cells and prevents lipopolysaccharide-induced blood-brain barrier leakage in mice.
    Zhang T; Zhang X; Lin C; Wu S; Wang F; Wang H; Wang Y; Peng Y; Hutchinson MR; Li H; Wang X
    J Neurochem; 2021 May; 157(3):611-623. PubMed ID: 33453127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heme induces inflammatory injury by directly binding to the complex of myeloid differentiation protein 2 and toll-like receptor 4.
    Lin J; Lin K; Huang L; Jiang Y; Ding X; Luo W; Samorodov AV; Pavlov VN; Liang G; Qian J; Wang Y
    Toxicol Lett; 2022 Nov; 370():15-23. PubMed ID: 36115635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic lipopolysaccharide transfer cascade to TLR4/MD2 complex via LBP and CD14.
    Kim SJ; Kim HM
    BMB Rep; 2017 Feb; 50(2):55-57. PubMed ID: 28115037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin Analog L48H37 Prevents Lipopolysaccharide-Induced TLR4 Signaling Pathway Activation and Sepsis via Targeting MD2.
    Wang Y; Shan X; Dai Y; Jiang L; Chen G; Zhang Y; Wang Z; Dong L; Wu J; Guo G; Liang G
    J Pharmacol Exp Ther; 2015 Jun; 353(3):539-50. PubMed ID: 25862641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human α
    Saenger T; Vordenbäumen S; Genich S; Haidar S; Schulte M; Nienberg C; Bleck E; Schneider M; Jose J
    Biochim Biophys Acta Gen Subj; 2019 Mar; 1863(3):632-643. PubMed ID: 30553868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human MD2 deficiency-an inborn error of immunity with pleiotropic features.
    Li Y; Yu Z; Schenk M; Lagovsky I; Illig D; Walz C; Rohlfs M; Conca R; Muise AM; Snapper SB; Uhlig HH; Garty BZ; Klein C; Kotlarz D
    J Allergy Clin Immunol; 2023 Mar; 151(3):791-796.e7. PubMed ID: 36462957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACT001 Inhibits TLR4 Signaling by Targeting Co-Receptor MD2 and Attenuates Neuropathic Pain.
    Zhang T; Lin C; Wu S; Jin S; Li X; Peng Y; Wang X
    Front Immunol; 2022; 13():873054. PubMed ID: 35757727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.